Zinc as a Drug for Wilson’s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury

Zinc is the second most abundant trace element in the human body, and it plays a fundamental role in human physiology, being an integral component of hundreds of enzymes and transcription factors. The discovery that zinc atoms may compete with copper for their absorption in the gastrointestinal trac...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pierpaolo Coni, Giuseppina Pichiri, Joanna Izabela Lachowicz, Alberto Ravarino, Francesca Ledda, Daniela Fanni, Clara Gerosa, Monica Piras, Ferdinando Coghe, Yukio Gibo, Flaviana Cau, Massimo Castagnola, Peter Van Eyken, Luca Saba, Marco Piludu, Gavino Faa
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/bf0a52c760d54bef9761ab426a8f9ad7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bf0a52c760d54bef9761ab426a8f9ad7
record_format dspace
spelling oai:doaj.org-article:bf0a52c760d54bef9761ab426a8f9ad72021-11-11T18:35:08ZZinc as a Drug for Wilson’s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury10.3390/molecules262166141420-3049https://doaj.org/article/bf0a52c760d54bef9761ab426a8f9ad72021-10-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/21/6614https://doaj.org/toc/1420-3049Zinc is the second most abundant trace element in the human body, and it plays a fundamental role in human physiology, being an integral component of hundreds of enzymes and transcription factors. The discovery that zinc atoms may compete with copper for their absorption in the gastrointestinal tract let to introduce zinc in the therapy of Wilson’s disease, a congenital disorder of copper metabolism characterized by a systemic copper storage. Nowadays, zinc salts are considered one of the best therapeutic approach in patients affected by Wilson’s disease. On the basis of the similarities, at histological level, between Wilson’s disease and non-alcoholic liver disease, zinc has been successfully introduced in the therapy of non-alcoholic liver disease, with positive effects both on insulin resistance and oxidative stress. Recently, zinc deficiency has been indicated as a possible factor responsible for the susceptibility of elderly patients to undergo infection by SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic. Here, we present the data correlating zinc deficiency with the insurgence and progression of Covid-19 with low zinc levels associated with severe disease states. Finally, the relevance of zinc supplementation in aged people at risk for SARS-CoV-2 is underlined, with the aim that the zinc-based drug, classically used in the treatment of copper overload, might be recorded as one of the tools reducing the mortality of COVID-19, particularly in elderly people.Pierpaolo ConiGiuseppina PichiriJoanna Izabela LachowiczAlberto RavarinoFrancesca LeddaDaniela FanniClara GerosaMonica PirasFerdinando CogheYukio GiboFlaviana CauMassimo CastagnolaPeter Van EykenLuca SabaMarco PiluduGavino FaaMDPI AGarticlezincCOVID-19Wilson’s diseasenon-alcoholic liver diseasedrug therapyOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6614, p 6614 (2021)
institution DOAJ
collection DOAJ
language EN
topic zinc
COVID-19
Wilson’s disease
non-alcoholic liver disease
drug therapy
Organic chemistry
QD241-441
spellingShingle zinc
COVID-19
Wilson’s disease
non-alcoholic liver disease
drug therapy
Organic chemistry
QD241-441
Pierpaolo Coni
Giuseppina Pichiri
Joanna Izabela Lachowicz
Alberto Ravarino
Francesca Ledda
Daniela Fanni
Clara Gerosa
Monica Piras
Ferdinando Coghe
Yukio Gibo
Flaviana Cau
Massimo Castagnola
Peter Van Eyken
Luca Saba
Marco Piludu
Gavino Faa
Zinc as a Drug for Wilson’s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury
description Zinc is the second most abundant trace element in the human body, and it plays a fundamental role in human physiology, being an integral component of hundreds of enzymes and transcription factors. The discovery that zinc atoms may compete with copper for their absorption in the gastrointestinal tract let to introduce zinc in the therapy of Wilson’s disease, a congenital disorder of copper metabolism characterized by a systemic copper storage. Nowadays, zinc salts are considered one of the best therapeutic approach in patients affected by Wilson’s disease. On the basis of the similarities, at histological level, between Wilson’s disease and non-alcoholic liver disease, zinc has been successfully introduced in the therapy of non-alcoholic liver disease, with positive effects both on insulin resistance and oxidative stress. Recently, zinc deficiency has been indicated as a possible factor responsible for the susceptibility of elderly patients to undergo infection by SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic. Here, we present the data correlating zinc deficiency with the insurgence and progression of Covid-19 with low zinc levels associated with severe disease states. Finally, the relevance of zinc supplementation in aged people at risk for SARS-CoV-2 is underlined, with the aim that the zinc-based drug, classically used in the treatment of copper overload, might be recorded as one of the tools reducing the mortality of COVID-19, particularly in elderly people.
format article
author Pierpaolo Coni
Giuseppina Pichiri
Joanna Izabela Lachowicz
Alberto Ravarino
Francesca Ledda
Daniela Fanni
Clara Gerosa
Monica Piras
Ferdinando Coghe
Yukio Gibo
Flaviana Cau
Massimo Castagnola
Peter Van Eyken
Luca Saba
Marco Piludu
Gavino Faa
author_facet Pierpaolo Coni
Giuseppina Pichiri
Joanna Izabela Lachowicz
Alberto Ravarino
Francesca Ledda
Daniela Fanni
Clara Gerosa
Monica Piras
Ferdinando Coghe
Yukio Gibo
Flaviana Cau
Massimo Castagnola
Peter Van Eyken
Luca Saba
Marco Piludu
Gavino Faa
author_sort Pierpaolo Coni
title Zinc as a Drug for Wilson’s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury
title_short Zinc as a Drug for Wilson’s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury
title_full Zinc as a Drug for Wilson’s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury
title_fullStr Zinc as a Drug for Wilson’s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury
title_full_unstemmed Zinc as a Drug for Wilson’s Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury
title_sort zinc as a drug for wilson’s disease, non-alcoholic liver disease and covid-19-related liver injury
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/bf0a52c760d54bef9761ab426a8f9ad7
work_keys_str_mv AT pierpaoloconi zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT giuseppinapichiri zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT joannaizabelalachowicz zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT albertoravarino zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT francescaledda zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT danielafanni zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT claragerosa zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT monicapiras zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT ferdinandocoghe zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT yukiogibo zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT flavianacau zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT massimocastagnola zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT petervaneyken zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT lucasaba zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT marcopiludu zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
AT gavinofaa zincasadrugforwilsonsdiseasenonalcoholicliverdiseaseandcovid19relatedliverinjury
_version_ 1718431784995127296